#5216 on the rich list of 14,644 insiders
Kenneth Myszkowski
Chief Financial Officer at Arrowhead Pharmaceuticals. Based in Pasadena, California.
$19.9M
in disclosed stock, +$246K (+1.25%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 5216th of 14,644
- Companies held
- 1
- Largest holding
- ARWR, 100.0% of total
- Latest SEC filing
- Jan 7, 2025
What the $19.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ARWR Common Stock | Directly | 455,433 | $43.65 | $19.9M | 100.0% | Form 4, Jan 7, 2025 |
Share counts are the amounts Kenneth Myszkowski reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5213 | Kevin J. Hanigan President & COO, Prosperity Bancshares. Sugar Land, TX | $19.9M |
| 5214 | Asaf Silberstein EVP and COO, Semtech. Camarillo, CA | $19.9M |
| 5215 | Matthew J. Stevenson President & CEO, Blue Bird. Nashville, TN | $19.9M |
| 5216 | Kenneth Myszkowski Chief Financial Officer, Arrowhead Pharmaceuticals. Pasadena, CA | $19.9M |
| 5217 | Christopher Clemente Chairman & CEO, Comstock Holding Companies. Reston, VA | $19.9M |
| 5218 | Emily Ho Chief Accounting Officer, Snowflake. Menlo Park, CA | $19.9M |
| 5219 | Michael T. Prior Director, ATN International. Beverly, MA | $19.9M |
Other Arrowhead Pharmaceuticals insiders
All ARWR insiders- Christopher Anzalone$166MChief Executive Officer. #1025 overall
- Patrick O'Brien$23.9MCOO. #4533 overall
- James Hamilton$9.9MChief Medical Officer. #8850 overall
- Javier San Martin$8.7MChief Medical Officer. #9742 overall
- Daniel Joseph Apel$7.1MChief Financial Officer. #11271 overall
- Tracie Oliver$5.5MChief Commercial Officer. #13467 overall
Questions
How much stock does Kenneth Myszkowski own?
Kenneth Myszkowski holds $19,879,650 in listed stock based on SEC filings and current prices, mostly Arrowhead Pharmaceuticals (ARWR). That ranks 5216th on the Stock Rich List.
Is this Kenneth Myszkowski's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.